Published • loading... • Updated
Clinical Trial Finds Full-Spectrum CBD Well Tolerated in Adults With HIV
Summary by The Marijuana Herald
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Clinical Trial Finds Full-Spectrum CBD Well Tolerated in Adults With HIV
The Marijuana Herald - Marijuana news and information A randomized clinical trial found that low-dose full-spectrum cannabidiol (CBD) was well tolerated over 12 weeks among adults with long-term, virally suppressed HIV, with no meaningful negative impact on liver function, kidney function or key HIV-related measures. The study, published in Cannabis & Cannabinoid Research, was conducted by researchers affiliated with Centre Hospitalier Universit…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
